Individual-based modelling
How local cell-level rules generate tissue-level behaviour, and how model structure can make assumptions testable rather than hidden.
My interests are intentionally framed as directions for further study, not as claims of participation in a laboratory programme. They align with publicly documented work in Sheffield’s Complex Systems Modelling group: individual-based models, multiscale biomedical modelling, Electrical Impedance Spectroscopy and machine-learning decision support.
How local cell-level rules generate tissue-level behaviour, and how model structure can make assumptions testable rather than hidden.
How measurements, mechanistic simulation and statistical learning can be connected across scales without confusing model fit with biological explanation.
How signal quality, probe/device variation, cohort composition and calibration affect the validity of decision-support models.
These questions reflect my interest in building evidence chains rather than optimising a single headline metric.
When different parameter combinations produce similar outputs, what experiments or priors are needed before parameters can be interpreted biologically?
Which parameters dominate outcomes, which uncertainties are reducible, and how should uncertainty propagate into a final recommendation?
Can a model withstand subject-separated testing, temporal change, hardware differences and new populations rather than only a random internal split?
What prospective or workflow-level evidence is needed before a retrospective classifier can support a real decision?
Contribution: a modern learning approach for EIS-based detection. Questions: patient-level splitting, cohort selection, calibration, class balance, device/site shift and prospective validation.
Contribution: scalable agent-based simulation. Questions: whether speed and scale preserve biological fidelity, and how parameters and emergent behaviours are validated against independent observations.
Contribution: mechanistic hypotheses across interacting cell processes. Questions: calibration strategy, global sensitivity, structural alternatives and what evidence would discriminate explanation from curve-fitting.
Contribution: linking tissue structure to simulated measurements. Questions: morphology distributions, parameter uncertainty, measurement realism and validation against held-out physical data.